Financial calendar

February 28, 2019

Year-end report for the period January 1 – December 31, 2018

April 15, 2019

Annual report 2018

April 29, 2019

Interim Report Q1 January–March 2019

May 22, 2019

Annual general meeting 2019

August 22, 2019

Interim Report Q2 April–June 2019

November 15, 2019

Interim Report Q3 July–September 2019

February 28, 2020

Interim report Q4 October – December 2019

April 15, 2020

Annual report 2019

May 5, 2020

Interim report Q1 January – March 2020

May 20, 2020

Annual General Meeting 2020

August 25, 2020

Interim report Q2 April – June 2020

September 1, 2020 09:00 CET

Redeye: Live presentation with Alzecure Pharma

November 17, 2020

Interim Report Q3 July – September 2020

February 26, 2021

Year-end report for the period January–December 2020

April 6, 2021

Annual Report 2020

May 5, 2021

Interim report for the period January – March 2021

May 17, 2021

Annual General Meeting 2021

August 25, 2021

Interim report for the period April – June 2021

October 7, 2021 10:20 CET Stockholm Epicenter

Vator Healthcare Innovation Summit

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s d...

November 10, 2021

Interim report for the period July – September 2021

February 24, 2022

Year-end report for the period January–December 2021

March 1, 2022

Extraordinary General Meeting 2022

April 6, 2022

Annual Report 2021

May 5, 2022

Interim report for the period January – March 2022

May 17, 2022

Annual General Meeting 2022

August 25, 2022

Interim report for the period April – June 2022

November 10, 2022

Interim report for the period July – September 2022

February 24, 2023

Year-end report for the period January–December 2022

April 5, 2023 (Previously April 6, 2023)

Annual Report 2022

May 4, 2023 (Previously May 5, 2023)

Interim report for the period January – March 2023

May 17, 2023

Annual General Meeting 2023

August 24, 2023 (Previously August 25, 2023)

Interim report for the period April – June 2023

November 9, 2023 (Previously November 10, 2023)

Interim report Q3, July–September 2023

February 27, 2024

Interim report Q4, October–December 2023

April 4, 2024

Annual report 2023

April 25, 2024

Interim report Q1, January-March 2024

May 14, 2024

Annual general meeting 2024

August 26, 2024

Interim report Q2, April-June 2024

November 11, 2024

Interim report Q3, July-September 2024